Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

References

Page 1

	Year	Citations
LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN E. P. Krenning, Wout A. P. Breeman, P.P.M. Kooij, The Lancet MedicineNeuroendocrine DisorderPathologyEndocrinologyOncology	1989	620
Classification and nomenclature of somatostatin receptors Daniël Hoyer, G I Bell, Michael Berelowitz, Trends in Pharmacological Sciences Signal TransductionSomatostatin Receptor NomenclatureSst5 Receptor SubtypesFunctional SelectivityMedicine	1995	570
Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Jean Claude Reubi, Larry K. Kvols, Beatrice Waser, PubMed Tumor BiologyEndocrine OncologyReceptor StatusMedicineSurgical Pathology	1990	380
Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy A. Heppeler, Sylvie Froidevaux, Helmut R. Mäcke, Chemistry - A European Journal Peptide EngineeringPeptide SciencePeptide TherapeuticsInternal RadiotherapyMedicinal Chemistry	1999	332
Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Kamal Kant Sharma, Yogesh Patel, Coimbatore B. Srikant Molecular Endocrinology ApoptosisCell DeathCancer BiologyTumor BiologyCell Regulation	1996	257
DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy Andreas Otte, E. Jermann, Martin Béhé, European Journal of Nuclear Medicine and Molecular Imaging EngineeringNovel TherapyPowerful New ToolMedicineRadionuclide Therapy	1997	214
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy Marion de Jong, Willem H. Bakker, Eric P. Krenning, European Journal of Nuclear Medicine and Molecular Imaging Promising Somatostatin AnalogueEngineeringIndium-111 LabellingNovel TherapyMedicine	1997	212
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy. M. de Jong, W A Breeman, WH Bakker, PubMed EngineeringChemoprevention StrategyIn-labeled SomatostatinTumor BiologyMedicinal Chemistry	1998	210
Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. Yona Greenman, Shlomo Melmed The Journal of Clinical Endocrinology & Metabolism Sstr3 ExpressionPathologyTumor BiologySstr5 ExpressionPituitary Gland	1994	177
Somatostatin receptor subtypes sst1, sst2, sst3 and sst5expression in human pituitary, gastroentero-pancreatic and mammary tumors Jean‐Claude Schaer, Beatrice Waser, Guadalupe Mengod, International Journal of Cancer Mammary TumorsSst ExpressionPathologyVarious Sst MrnasTumor Biology	1997	149

Page 1